SynDRA canonical compound SYN0002260 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HRH1 |
| Mechanism of action | L-type calcium channel blocker |
| Indication | allergic rhinitis | conjunctivitis | dermatographism | vasomotor rhinitis |
| Disease area | allergy | dermatology | ophthalmology | otolaryngology |